首页|新型隐球菌耐药性和药物耐受性检测及其机制研究进展

新型隐球菌耐药性和药物耐受性检测及其机制研究进展

扫码查看
新型隐球菌是全球分布的机会性真菌病原体,引起的隐球菌脑膜炎是获得性免疫缺陷综合征患者死亡的重要因素之一.目前,抗真菌治疗药物的种类有限,一定程度上加剧了新型隐球菌的耐药性和药物耐受性.在一些病例中,即使用体外药物敏感性试验结果提示敏感的药物进行治疗,病情依然迁延不愈或复发.这可能与药物耐受性有关.药物耐受性的发现,反映了更为复杂的抗真菌药物耐药机制.了解新型隐球菌耐药性和药物耐受性及其机制至关重要,可为制定临床治疗方案和开发新型抗真菌药物提供思路.
Research progress on determination and mechanism of drug resistance and tolerance to Cryptococcus neoformans
Cryptococcus neoformans is a globally distributed opportunistic fungal pathogen,which causes cryptococcal meningitis,a factor in the mortality of acquired immune deficiency syndrome patients.At present,the kinds of antifungal drugs are limited,which causes in drug resistance and tolerance to Cryptococcus neoformans.In some cases,even if the in vitro drug susceptibility test suggests sensitivity,the treatment with the drug is still prolonged or relapses.This may be associated with drug tolerance.The discovery of drug tolerance responds to more complex mechanisms of antifungal drug resistance.Understanding the drug resistance and tolerance to Cryptococcus neoformans as well as the mechanisms is critical,which can provide ideas for clinical treatment regimen design and the development of new antifungal drugs.

Cryptococcus neoformansDrug resistanceDrug tolerance

王子文、吴文娟

展开 >

同济大学医学院,上海 200092

同济大学附属东方医院南院检验科,上海 200123

新型隐球菌 耐药 药物耐受

2024

检验医学
上海市临床检验中心

检验医学

CSTPCD
影响因子:1.715
ISSN:1673-8640
年,卷(期):2024.39(12)